Triton Pacific Healthcare Partners

The firm pursues a buy-and-build approach in US healthcare services, acquiring founder-owned physician practices in fragmented specialties. It typically targets practices with $2 million to $10 million in EBITDA and consolidates them into larger platform groups. The strategy relies on operational improvements, centralized administration, and enhanced payer contracting to drive margin expansion.

The firm has historically concentrated on dental, dermatology, gastroenterology, and eye care — sub-sectors with high fragmentation, strong cash-pay or insurance-reimbursed revenue streams, and a clear path to scaling through add-on acquisitions. These verticals share a common profile of independent owner-operators approaching retirement with limited internal succession options.

Triton Pacific invests through committed capital vehicles — pooled private equity funds — rather than on a deal-by-deal basis. This fund structure aligns with the firm's buy-and-build model, where multiple add-on acquisitions follow an initial platform investment, requiring reserved dry powder over a multi-year deployment period.

Triton Pacific Healthcare Partners is a sector-specific affiliate under the broader Triton Pacific umbrella. Triton Pacific Capital Partners historically ran a diversified private equity program that included a healthcare vertical, and Triton Pacific Healthcare Partners was structured to operate that vertical with dedicated focus, team, and branding.

There is no public evidence that Triton Pacific Healthcare Partners maintains a formal co-investment program for outside limited partners. The firm has not marketed co-investment sleeves, SPVs, or separately managed accounts to external allocators. Its capital likely comes entirely through its main fund vehicles, though this should be confirmed directly with the firm.